Newron Pharmaceuticals SpA (NWRN) — Net Asset Momentum
Newron Pharmaceuticals SpA (NWRN) recorded a net asset momentum of -863.1% as of December 2025, with net assets of CHF-11.13 Million CHF. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Newron Pharmaceuticals SpA book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Newron Pharmaceuticals SpA Net Asset Momentum (2005–2025)
This chart tracks Newron Pharmaceuticals SpA's year-over-year net asset growth across 21 annual reporting periods from 2005 to 2025. The most recent momentum reading is -863.1%, with net assets of CHF-11.13 Million CHF as of December 2025. For live market cap and overall valuation, see NWRN market cap.
Annual Net Asset History for Newron Pharmaceuticals SpA (2005–2025)
The table below shows the complete annual net asset history for Newron Pharmaceuticals SpA from 2005 to 2025, covering 21 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Newron Pharmaceuticals SpA to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CHF) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CHF-11.13 Million | CHF40.02 Million | CHF51.15 Million | ▼ -863.1% |
| 2024 | CHF1.46 Million | CHF63.91 Million | CHF62.45 Million | ▲ +104.9% |
| 2023 | CHF-29.91 Million | CHF25.87 Million | CHF55.77 Million | ▼ -113.2% |
| 2022 | CHF-14.03 Million | CHF37.20 Million | CHF51.23 Million | ▼ -551.6% |
| 2021 | CHF3.11 Million | CHF50.49 Million | CHF47.38 Million | ▼ -82.0% |
| 2020 | CHF17.25 Million | CHF51.20 Million | CHF33.95 Million | ▼ -53.1% |
| 2019 | CHF36.80 Million | CHF60.29 Million | CHF23.49 Million | ▼ -32.9% |
| 2018 | CHF54.84 Million | CHF60.00 Million | CHF5.16 Million | ▼ -19.0% |
| 2017 | CHF67.72 Million | CHF73.02 Million | CHF5.30 Million | ▲ +36.1% |
| 2016 | CHF49.75 Million | CHF56.59 Million | CHF6.84 Million | ▲ +34.0% |
| 2015 | CHF37.11 Million | CHF44.38 Million | CHF7.27 Million | ▲ +26.8% |
| 2014 | CHF29.26 Million | CHF37.07 Million | CHF7.81 Million | ▲ +38.7% |
| 2013 | CHF21.09 Million | CHF31.62 Million | CHF10.53 Million | ▼ -23.6% |
| 2012 | CHF27.61 Million | CHF44.65 Million | CHF17.04 Million | ▲ +319.3% |
| 2011 | CHF6.58 Million | CHF13.57 Million | CHF6.98 Million | ▼ -46.0% |
| 2010 | CHF12.19 Million | CHF19.13 Million | CHF6.94 Million | ▼ -58.4% |
| 2009 | CHF29.28 Million | CHF41.68 Million | CHF12.39 Million | ▼ -36.1% |
| 2008 | CHF45.81 Million | CHF60.54 Million | CHF14.73 Million | ▼ -20.2% |
| 2007 | CHF57.40 Million | CHF70.37 Million | CHF12.97 Million | ▼ -15.4% |
| 2006 | CHF67.86 Million | CHF86.16 Million | CHF18.30 Million | ▲ +298.7% |
| 2005 | CHF17.02 Million | CHF23.50 Million | CHF6.48 Million | — |